Latest News from Alsace DNA x Dianosic
Discover our other articles
Dianosic launches a WiSEED backed convertible bonds transaction to accelerate innovation in the treatment of chronic allergic rhinitis. This initiative aims to support the…
Apr 28, 2025
Dianosic shortlisted for the “Trophées des Entreprises Alsace 2024” award
Awards
We are delighted to announce that Dianosic is one of the nominees for the 2024 edition of the “Trophées des entreprises d’Alsace”. This selection…
Dianosic joins France Deeptech! 🇫🇷 🚀 We are delighted to inform you of Dianosic’s official integration into the deeptech ecosystem! A dynamic network that…
